AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05042934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Hydrochloride
Description: Given IV
Study NCT05042934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurbinectedin
Description: Given IV
Study NCT05626426 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive, Transorbital Alternating Current Stimulation (rtACS)
Description: Patients receive treatment every other day via a headband that delivers electrical stimulation to the retina
Study NCT05684471 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Suprainguinal Fascia iliaca Block
Description: Patients in this group will be administered SFIB with 50 mL of local anesthetic solution (Bupivacaine %0.25) under ultrasound guidance after the surgery is completed.
Study NCT05684471 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Anterior Quadratus Lumborum Block
Description: Patients in this group will be administered anterior QLB with 40 mL of local anesthetic (Bupivacaine %0.25) under ultrasound guidance after the surgery is completed.
Study NCT06163599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Telenovela Intervention
Description: The intervention constitutes nine videos depicting the main character, Esperanza, who is struggling with anxiety and depression, undergoing therapy involving the a trandiagnostic treatment, and completing worksheets relating to the weekly therapy sessions.
Study NCT06213870 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Surgical criteria
Description: In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication.~In the perfusion group, patients who meet the criteria of DEFUSE3 will receive EVT surgery, otherwise receive medication.
Study NCT05726760 — intervention group
Intervention type: BEHAVIORAL
Intervention: Seeking informed consent for participation in the study.
Description: The parturients will undergo an informed consent process including an explanation of the methods and risks of the study. The Anaesthetist or researcher will conduct this process. A patient information leaflet will be provided for the parturients.
Study NCT05726760 — intervention group
Intervention type: DEVICE
Intervention: Temperature measurement by Braun Welch Allyn tympanic membrane thermometer device to the dorsum of the right and left feet above space between the 2nd and 3rd metatarsal bones.
Description: The Anaesthetist or researcher and recovery nurse will conduct the intervention in theatre and in the recovery ward.
Study NCT06409299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin 40 MG/ML
Description: Maintenance Antibiotic treatment
Study NCT06409299 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05670834 — intervention group
Intervention type: GENETIC
Intervention: genotyping assay by real-time PCR
Description: genotyping assay of MMP-2 gene with the real-time polymerase chain reaction
Study NCT05670834 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ELISA
Description: . IL-6 level in serum will be analyzed by ELISA assay kit.
Study NCT05897632 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Outpatient Evaluation
Description: Subjects will receive an outpatient evaluation within 72 of being discharged from the ED.
Study NCT05897632 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Hospitalization Evaluation
Description: Patients randomized to this arm receive evaluation for their symptoms in a hospital ward, observation unit, or emergency department boarding.
Study NCT06162897 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dyadic Case Management
Description: Subjects enrolled in the intervention arm will be offered focused case management centered around goal setting and future orientation. Subjects will be assigned two case managers to support their goals.
Study NCT06522724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education program
Description: Patients in a study group will participate in daily education program using an original brochure containing information about self-management during the treatment process, the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise.
Study NCT06522724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Description: The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.
Study NCT06522724 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pulmonary rehabilitation
Description: The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.
Study NCT05746754 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CSI
Description: 30 Gy in 10 fractions to CNS
Study NCT06553053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Harmonizing Shaoyang, nourishing spleen and kidney with warmth Acupuncture Group
Description: Patients receiving acupuncture and mild moxibustion, whom were treated 2 times per week for 12 weeks and followed up for 40 weeks. The first group of acupoints is that CV4 and Bilateral ST37, SP6, SP4, KI3, LI11, SJ4 and GB26 were selected for acupuncture and CV12 and bilateral ST36 and GB41 were selected for moxibustion. The second group of acupoints is that CV12 and Bilateral ST36, GB41, SP4, KI3, LI11, SJ4 and GB26 were selected for acupuncture and CV4 and bilateral SP6 and GB34 were selected for moxibustion. These two groups are alternate. After deqi sensation was even reinforcing and reducing. The surface temperature of acupoints was maintained at 43℃± 1℃ for moxibustion. During each treatment, acupuncture and mild moxibustion are performed simultaneously, both lasting for 30 minutes.
Study NCT06553053 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nourishing spleen and kidney with warmth Acupuncture Group
Description: Patients receiving acupuncture and mild moxibustion, whom were treated 2 times per week for 12 weeks and followed up for 40 weeks. The first group of acupoints is that CV4 and Bilateral ST37, SP6, SP4, KI3 and LI11 were selected for acupuncture and CV12 and bilateral ST36 were selected for moxibustion. The second group of acupoints is that CV12 and Bilateral ST36, SP4, KI3 and LI11 were selected for acupuncture and CV4 and bilateral SP6 were selected for moxibustion. These two groups are alternate. After deqi sensation was even reinforcing and reducing. The surface temperature of acupoints was maintained at 43℃± 1℃ for moxibustion. During each treatment, acupuncture and mild moxibustion are performed simultaneously, both lasting for 30 minutes.
Study NCT06332404 — intervention group
Intervention type: DEVICE
Intervention: Hypoglossal nerve stimulation Inspire system (Inspire Medical Systems Inc., USA)
Description: Hypoglossal nerve stimulation therapy
Study NCT05393804 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ide-cel (bb2121)
Description: Eligible patients will undergo leukapheresis, receive lymphodepleting (LD) chemotherapy followed by infusion of Ide-Cel or Cilta-Cel, and be monitored daily for 14 days, three times a week until day + 30 after CAR T infusion and monthly until 12 months post CAR T infusion.
Study NCT06290882 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic Heller Myotomy
Description: Use five trocar technique with patient in the French position. Establish 12-15 mm Hg pneumoperitoneum. Divide phrenoesophageal ligament starting on the right and mobilize distal esophagus on the lateral and anterior side. Identify and spare anterior vagal nerve. Perform myotomy by dividing both muscle-layers extending at least 7 cm above gastroesophageal junction and 2 cm inferiorly over stomach. Measure myotomy length. Perform anterior fundoplication without mobilizeng fundus of the stomach by dividing short gastric vessels if not necessary. Suture fundus to both cut edges of myotomy, using non-resorbable material.
Study NCT06290882 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Peroral Endoscopic Myotomy
Description: After lavage, measure gastro-esophageal junction (GEJ) in cm from mouth piece. Determine entry point 12-14cm above GEJ at the lesser curvature site, inject 10ml coloured saline, create entry point. Advance endoscope into the submucosa, dissect the submucosal tunnel up to 2-3cm into the cardia. Dissect the submucosa close to the muscularis and check endoluminally for the direction of the lesser curvature, sufficient extension onto the cardia and mucosal integrity. After tunnel completion flush with gentamycin and saline. Start myotomy from proximally to distally starting 4-5cm below the mucosal entry site; the inner circular muscle layer should be fully dissected especially at the cardia for good symptomatic results. It is vital that the mucosa of the tubular esophagus remains intact. Extend myotomy at least 2cm onto the cardia. After completion check for mucosal integrity and opening of the distal esophageal sphincter. Close the entry point with clips from distal to proximal.
Study NCT04942431 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rebirth active SCHOOL 2.0 movement program
Description: 60 Minutes of physical activity per day integrated in every school-day.
Study NCT05001529 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti IL5 receptor antibodies
Description: Subjects with severe uncontrolled asthma will be assigned to treatment with Omalizumab (anti Ig E antibodies) or Mepolizumab (anti IL-5 antibodies) according to medical advice and standardized protocols for asthma treatment.
Study NCT05726760 — intervention group
Intervention type: DEVICE
Intervention: Covidien Mon-a-Therm skin temperature probes will be applied to the dorsum of the right and left feet above space between the 2nd and 3rd metatarsal bones.
Description: The Anaesthetist or researcher will conduct the intervention in theatre. The probes will be removed in the recovery ward.
Study NCT05726760 — intervention group
Intervention type: DEVICE
Intervention: Temperature measurement by Braun Welch Allyn tympanic membrane thermometer device to the ear.
Description: The Anaesthetist or researcher and recovery nurse will conduct the intervention in theatre and in the recovery ward.
Study NCT03792360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SVF (Stromal Vascular Fraction)
Description: The stromal vascular fraction (SVF), isolated when fresh lipoaspirates are enzymatically digested with a collagenase, contains a heterogeneous cellular and extracellular milieu. SVF is an aqueous fraction, consisting of endothelial cells and their precursors, macrophages, smooth muscle cells, lymphocytes, pericytes, pre-adipocytes and actual AMSCs.
Study NCT05554185 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: aspirin 100mg and probiotics 1 bag
Description: taking aspirin 100mg and probiotics 1 bag per day from 14-16 weeks of pregnancy until 35 + 6 weeks of pregnancy or emergency delivery.
Study NCT05554185 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: aspirin 100mg and probiotics 1 bag
Description: taking aspirin 100mg and probiotics 1 bag per day from 14-16 weeks of pregnancy until 35 + 6 weeks of pregnancy or emergency delivery.
Study NCT05860478 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearable device
Description: The wearable device includes a motion sensor, and is worn around the wrist, and the device records a participant's physical activity .
Study NCT05246514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Description: administered as an IV infusion
Study NCT05685784 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bytelfies kit - sensor dot
Description: Participants will be asked to undergo a standard of care gait analysis and PSG whilst simultaneously wearing sensor dots.~GAIT: sensor dots will be placed in the neck, on the chest and one on both ankles.~PSG: sensor dots will be placed on the forehead, chin, chest, abdomen, both legs(tibialis anterior) and an SpO2 device will be placed on the finger middle finger of the non-dominant hand
Study NCT05511402 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: People with Parkinson's Disease will be received a supervised physiotherapy and rehabilitation program.
Study NCT05511402 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: People with Parkinson's Disease will be received a supervised physiotherapy and rehabilitation program.
Study NCT05162690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10 milligram
Description: 10mg per day of Dapagliflozin will be given to the patients
Study NCT05162690 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Metformin DPP4 inhibitors
Study NCT06372795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pure effortful swallowing
Description: The investigator instructed the patient to swallow forcefully while squeezing the tongue upward and backward in the direction of the soft palate based on the sounds of an electronic timer.
Study NCT06372795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive resistance swallowing training
Description: Patients in the test group, resistance swallowing exercise was performed by providing external resistance through Iowa Oral Performance Instrument (IOPI), and all other protocols were performed the same as those in the control group.
Study NCT05529472 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral Orbital Atherectomy System (OAS)
Description: Treatment with Orbital Atherectomy System (OAS) followed by Percutaneous Old Balloon Angioplasty (POBA), pre-dilation and Drug Coated Balloon (DCB) - Medtronic IN.PACT™ Admiral™
Study NCT05364996 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: bronchial endoscopy with bronchoalveolar lavage (LBA)
Description: Bronchial endoscopy under laryngeal mask and general anesthesia. BAL of saline at room temperature of 3 milliliters per kilogram limited to 20 milliliters x 3 according to recommendations
Study NCT05364996 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: collection of 5 milliliters of blood for total white cells count, C-Reactive Protein, specific immunoglobulin E assays, serum sRAGE assay
Study NCT06015477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Description: starting dose of ticagrelor was a single loading dose of 180mg (90mg x 2 tablets) and thereafter 1 tablet (90mg) each time, twice daily.
Study NCT06015477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dual Antiplatelet Therapy
Description: Clopidogrel 75mg + Aspirin 100mg 1 month, after 1 month, change to aspirin 100mg 1 year.
Study NCT05211999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precede-Proceed Model Based Simulation Experience
Description: The program was created on the basis of the PRECEDE-PROCEED Model.The program consists of eight phases. It will be carried out with theoretical training and simulation experience in the experimental group. In the control group, theoretical training will be given. Results will be followed.
Study NCT05211999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No intervention in control group just theoretical education was done for them.
Study NCT06141941 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CGM
Description: Continuous glucose monitoring
Study NCT05431049 — intervention group
Intervention type: PROCEDURE
Intervention: Percutaneous nephrolithotomy surgery (PNL)
Description: Percutaneous nephrolithotomy (PNL) surgery was performed in all arms of the study to remove the renal stones. This surgery was performed with 2 anesthesia methods, CSEA and GA. These formed the groups of the study.
Study NCT04937725 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: eye tracking
Description: Eye tracker will be used to evaluate study parameters
Study NCT04772209 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium bicarbonate
Description: Dialysis catheter lumen will be filled (locked) by sodium bicarbonate solution. The amount of solution depends on the diameter and length and will be in accordance with the manufacturer's specifications.
Study NCT04772209 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: Dialysis catheter lumen will be filled (locked) by classic heparin. The amount of pure heparin depends on the diameter and length and will be in accordance with the manufacturer's specifications.
Study NCT06435637 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen protein
Description: Ingestion of 40, 20, 20 and 20 gram of collagen protein right after and every 2 hours after a bout of exercise
Study NCT04533815 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LOCK sleep intervention
Description: Nursing home staff are trained to use a collaborative problem-solving approach to sleep quality improvement using front-line huddling
Study NCT05009030 — intervention group
Intervention type: DRUG
Intervention: COVID-19 vaccine
Description: Lung cancer patients will receive an anti-COVID19 vaccine approved by the European Medicines Agency according to the guidelines approved by the regulatory authorities
Study NCT04656418 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSL312
Description: Fully human immunoglobulin G subclass 4/lambda recombinant monoclonal antibody
Study NCT04656418 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Buffer without active ingredient
Study NCT06435637 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: A single resistance exercise session of the leg press and leg extension exercise
Study NCT06435637 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Resistance exercise
Description: A single resistance exercise session of the leg press and leg extension exercise
Study NCT04853706 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 3d cam
Description: The 3D-CAM is a short interview that uses verbal responses and allows completion of the Confusion Assessment Method (CAM) diagnostic algorithm
Study NCT04853706 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: DSM 5
Description: The DSM-5 is the gold standard for diagnosing delirium. But proper use requires professional psychiatric background and training.
Study NCT04987021 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cochlear Implant (CI)-CI500 series, CI600 series or Freedom series cochlear implants
Description: The Remote Assist (RA) System is intended to support clinicians to conduct a remote programming session with their CI recipients.
Study NCT05284565 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Reading of the skin prick allergy test
Description: A double reading of the forearm will be performed with the Nexkin DSPT device. Also, two healthcare professionals will perform, consecutively, the manual reading according to their usual practice. Nexkin DSPT device provides a semi-automatic wheal detection, presenting the user an initial set of potential wheals and information about them (as their measure).~Healthcare professional can then discard, add and/or confirm wheals by visual validation, and add/edit wheal information. The device automates the test reading process, digitises the results, and quantifies.
Study NCT05938426 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ET-101
Description: Patients have training sessions twice a day. Each training session takes about 10\~25 minutes. Cognitive training programs include meditation, cognitive training, and cognitive testing.
Study NCT05938426 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Device
Description: Sham device has only cognitive function test excluding training programs.
Study NCT04913415 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low Suction Strategy of Chest Tube Management
Description: A digital chest tube will be set to a low pressure mode (-8mmHg) during recovery after minimally invasive lung resection.
Study NCT04913415 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Suction Strategy of Chest Tube Management
Description: A digital chest tube will be to the standard suction mode (-20mmHg) during recovery after minimally invasive lung resection.
Study NCT05708937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based phone app
Description: Creating mindfulness-based suggestions for infertile women:~Mindfulness-based content was created by taking the opinions of experts in the fields of women's health nursing, psychology and linguistics. It consists of 6 different parts. The content of meditation that the patient will apply according to the treatment stage is different. Infertility mindfulness departments; Breath Awareness, Body \& Uterus Awareness, Needle Therapy and Ovarian Awareness, Pre-Egg Collection (OPU) Diaphragm Breathing, Pre-embryo Transfer Uterine Awareness, Embryo and Uterine Awareness (Post transfer).~Audio recordings of mindfulness-themed meditation content:~After the meditation contents are planned; the sound recording was taken with a professional recorder (Sony ICD-PX470). The audio recordings taken were professionally edited by the expert. Mp3 recordings were created by adding background music to sound recordings in computer environment. Audio recordings of mindfulness-themed meditation content